BRUSSELS – The European Union and AstraZeneca agreed Friday to make public a heavily redacted version of their coronavirus vaccine agreement, which lies at the heart of a dispute over how many shots the pharmaceutical company should be supplying the EU's 27 nations.
The contract, agreed to last year by the European Commission and the drugmaker, allows the EU’s member countries to buy 300 million doses of the AstraZeneca vaccine, with an option for a further 100 million doses.
It’s one of several contracts the EU’s executive branch has with vaccine makers to secure a total of more than 2 billion shots.
As part of the “advanced purchase agreement" with vaccine companies, the EU has invested 336 million euros ($408 million) to finance the